Literature DB >> 2981332

Evidence for at least two dominant neutralization antigens on human rhinovirus 14.

B Sherry, R Rueckert.   

Abstract

A collection of 28 mutants of human rhinovirus 14, selected for resistance to 10 individual neutralizing monoclonal antibodies, was used to identify two major neutralization antigens, N-Ag I and N-Ag II. Isoelectric analysis showed that all 16 of the N-Ag I mutants analyzed were charge altered in VP1;8 of 12 N-Ag II mutants were altered in VP3. These results suggest that N-Ag I resides on VP1, whereas N-Ag II lies on VP3. The frequency of charge alterations was much higher than predicted by the genetic code, suggesting that charged amino acids on the antigenic sites play an important role in interaction with neutralizing antibody. Antibodies against N-Ag I and N-Ag II neutralize with widely different efficiencies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981332      PMCID: PMC254989     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Neutralizing site of poliovirus.

Authors:  F Brown
Journal:  Nature       Date:  1983 Aug 4-10       Impact factor: 49.962

2.  Poliovirus antigenic sites and vaccines.

Authors:  E Wimmer; B A Jameson; E A Emini
Journal:  Nature       Date:  1984 Mar 1-7       Impact factor: 49.962

3.  pH-dependent aggregation and electrofocusing of poliovirus.

Authors:  R Vrijsen; B Rombaut; A Boeye
Journal:  J Gen Virol       Date:  1983-10       Impact factor: 3.891

4.  Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides.

Authors:  E A Emini; B A Jameson; E Wimmer
Journal:  Nature       Date:  1983 Aug 25-31       Impact factor: 49.962

5.  Neutralization of poliovirus by antibody-mediated polymerization.

Authors:  P Brioen; D Dekegel; A Boeyé
Journal:  Virology       Date:  1983-06       Impact factor: 3.616

6.  Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry.

Authors:  J Icenogle; H Shiwen; G Duke; S Gilbert; R Rueckert; J Anderegg
Journal:  Virology       Date:  1983-06       Impact factor: 3.616

7.  Crystallization of a common cold virus, human rhinovirus 14: "isomorphism" with poliovirus crystals.

Authors:  J W Erickson; E A Frankenberger; M G Rossmann; G S Fout; K C Medappa; R R Rueckert
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

8.  Systematic nomenclature of picornavirus proteins.

Authors:  R R Rueckert; E Wimmer
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

9.  Temperature-sensitive mutants of foot-and-mouth disease virus with altered structural polypeptides. I. Identification by electrofocusing.

Authors:  A M King; J W Newman
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

10.  Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3.

Authors:  D M Evans; P D Minor; G S Schild; J W Almond
Journal:  Nature       Date:  1983 Aug 4-10       Impact factor: 49.962

View more
  76 in total

1.  Interaction of the poliovirus receptor with poliovirus.

Authors:  Y He; V D Bowman; S Mueller; C M Bator; J Bella; X Peng; T S Baker; E Wimmer; R J Kuhn; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Sequence and structure of human rhinoviruses reveal the basis of receptor discrimination.

Authors:  Marketa Vlasak; Soile Blomqvist; Tapani Hovi; Elizabeth Hewat; Dieter Blaas
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

3.  Production, purification, and capsid stability of rhinovirus C types.

Authors:  Theodor F Griggs; Yury A Bochkov; Kazuyuki Nakagome; Ann C Palmenberg; James E Gern
Journal:  J Virol Methods       Date:  2015-02-24       Impact factor: 2.014

4.  Site-specific mutations at a picornavirus VP3/VP1 cleavage site disrupt in vitro processing and assembly of capsid precursors.

Authors:  G D Parks; A C Palmenberg
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

5.  Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1.

Authors:  K J Wiegers; K Wetz; R Dernick
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

6.  Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells.

Authors:  M J Grubman; D O Morgan; J Kendall; B Baxt
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

7.  Effect of exogenous interferons on rhinovirus replication and airway inflammatory responses.

Authors:  Tess M Becker; Sandy R Durrani; Yury A Bochkov; Mark K Devries; Victoria Rajamanickam; Daniel J Jackson
Journal:  Ann Allergy Asthma Immunol       Date:  2013-08-28       Impact factor: 6.347

8.  The rhinovirus type 14 genome contains an internally located RNA structure that is required for viral replication.

Authors:  K L McKnight; S M Lemon
Journal:  RNA       Date:  1998-12       Impact factor: 4.942

9.  The time course of the humoral immune response to rhinovirus infection.

Authors:  W S Barclay; W al-Nakib; P G Higgins; D A Tyrrell
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

10.  Functional studies of truncated soluble intercellular adhesion molecule 1 expressed in Escherichia coli.

Authors:  S Martin; A Martin; D E Staunton; T A Springer
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.